San Diego, CA, United States of America

Ali Tajeldin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ali Tajeldin: Innovator in Bioinformatics

Introduction: Ali Tajeldin is an accomplished inventor based in San Diego, California, specializing in bioinformatics. His innovative work focuses on managing complex genomic data workflows, which plays a crucial role in advancing the field of genomics.

Latest Patents: Ali holds a patent for a method titled "Method for managing complex genomic data workflows." This invention efficiently processes and stores large datasets associated with multi-stage bioinformatics analyses of genomic data. The method enhances storage efficiency by automatically deleting or compressing intermediate data based on predetermined characteristics. It also ensures the consistent reproduction of output data by utilizing generated metadata tied to the stored data.

Career Highlights: Currently, Ali Tajeldin is employed at Onramp Bioinformatics, Inc., where he contributes his expertise to developing cutting-edge solutions for genomic data management. His work is instrumental in transforming how large genomic datasets are processed and stored, offering significant improvements in data handling and efficiency.

Collaborations: Throughout his career, Ali has collaborated with notable coworkers including Timothy Wesselman and Jeremy Davis-Turak. Their combined efforts focus on pushing the boundaries of what's possible in bioinformatics, fostering innovation and breakthroughs in the industry.

Conclusion: Ali Tajeldin's contributions to the field of bioinformatics through his patented invention not only enhance the efficiency of genomic data management but also underscore the importance of innovation in scientific research. His work at Onramp Bioinformatics, along with his collaborative endeavors, positions him as a key figure in advancing genomic technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…